Cladribine tablets in the treatment of patients with multiple sclerosis: an integrated analysis of infections in association with severe lymphopenia

被引：0
|
作者：
Cook, S. [1 ]
Leist, T. [2 ]
Comi, G. [3 ,4 ]
Montalban, X. [5 ]
Sylvester, E. [6 ]
Hicking, C. [6 ]
Dangond, F. [7 ]
机构：
[1] Rutgers State Univ, New Jersey Med Sch, Newark, NJ 07102 USA
[2] Thomas Jefferson Univ, Jefferson Med Coll, Div Clin Neuroimmunol, Philadelphia, PA 19107 USA
[3] Univ Vita Salute San Raffaele, Osped San Raffaele, Dept Neurol, Milan, Italy
[4] Univ Vita Salute San Raffaele, Osped San Raffaele, Inst Expt Neurol, Milan, Italy
[5] Hosp Univ Vall dHebron, Dept Neurol Neuroimmunol, Barcelona, Spain
[6] Merck KGaA, Darmstadt, Germany
[7] EMD Serono Inc, Billerica, MA USA
来源：
MULTIPLE SCLEROSIS JOURNAL | 2016年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P635
引用
收藏
页码：299 / 300
页数：2
相关论文
共 50 条
  • [21] INFECTIONS DURING GRADE 3/4 LYMPHOPENIA WITH CLADRIBINE TABLETS
    Cook, Stuart
    Leist, Thomas
    Comi, Giancarlo
    Montalban, Xavier
    Sylvester, Elke
    Hicking, Christine
    Dangond, Fernando
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2018, 89 (10):
  • [22] Integrated Safety Analysis of Infections during Periods of Grade 3 or 4 Lymphopenia in Patients Taking Cladribine Tablets 3.5 Mg/Kg
    Cook, Stuart
    Leist, Thomas P.
    Comi, Giancarlo
    Montalban, Xavier
    Sylvester, Elke
    Hicking, Christine
    Dangond, Fernando
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 43 - 43
  • [23] COVID-19 pneumonia in a multiple sclerosis patient with severe lymphopenia due to recent cladribine treatment
    Dersch, Rick
    Wehrum, Thomas
    Faehndrich, Sebastian
    Engelhardt, Monika
    Rauer, Sebastian
    Berger, Benjamin
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (10) : 1264 - 1266
  • [24] The Development of Cladribine Tablets for the Treatment of Multiple Sclerosis: A Comprehensive Review
    Rammohan, Kottil
    Coyle, Patricia K.
    Sylvester, Elke
    Galazka, Andrew
    Dangond, Fernando
    Grosso, Megan
    Leist, Thomas P.
    DRUGS, 2020, 80 (18) : 1901 - 1928
  • [25] Cladribine tablets for the treatment of relapsing-remitting multiple sclerosis
    Comi, Giancarlo
    Hartung, Hans-Peter
    Kurukulasuriya, Nuwan C.
    Greenberg, Steven J.
    Scaramozza, Matthew
    EXPERT OPINION ON PHARMACOTHERAPY, 2013, 14 (01) : 123 - 136
  • [26] The Development of Cladribine Tablets for the Treatment of Multiple Sclerosis: A Comprehensive Review
    Kottil Rammohan
    Patricia K. Coyle
    Elke Sylvester
    Andrew Galazka
    Fernando Dangond
    Megan Grosso
    Thomas P. Leist
    Drugs, 2020, 80 : 1901 - 1928
  • [27] The Clinical Pharmacology of Cladribine Tablets for the Treatment of Relapsing Multiple Sclerosis
    Hermann, Robert
    Karlsson, Mats O.
    Novakovic, Ana M.
    Terranova, Nadia
    Fluck, Markus
    Munafo, Alain
    CLINICAL PHARMACOKINETICS, 2019, 58 (03) : 283 - 297
  • [28] The Clinical Pharmacology of Cladribine Tablets for the Treatment of Relapsing Multiple Sclerosis
    Robert Hermann
    Mats O. Karlsson
    Ana M. Novakovic
    Nadia Terranova
    Markus Fluck
    Alain Munafo
    Clinical Pharmacokinetics, 2019, 58 : 283 - 297
  • [29] BUDGET IMPACT ANALYSIS OF CLADRIBINE TABLETS FOR TREATMENT OF PATIENTS WITH RELAPSING-REMITTING MULTIPLE SCLEROSIS IN BULGARIA
    Djambazov, S.
    Slavchev, G.
    Dineva, T.
    Panayotov, P.
    Vekov, T.
    VALUE IN HEALTH, 2018, 21 : S205 - S205
  • [30] Severe skin reactions associated with Cladribine treatment in patients with multiple sclerosis
    Mateo-Casas, Maria
    Reyes, Saul
    De Trane, Stefania
    Yildiz, Ozlem
    Turner, Benjamin
    Mathews, Joela
    Giovannoni, Gavin
    O'toole, Edel
    Schmierer, Klaus
    NEUROLOGY, 2019, 92 (15)
12345